GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Labiana Health SA (XMAD:LAB) » Definitions » Accounts Payable & Accrued Expense

Labiana Health (XMAD:LAB) Accounts Payable & Accrued Expense : €14.41 Mil (As of Dec. 2022)


View and export this data going back to 2022. Start your Free Trial

What is Labiana Health Accounts Payable & Accrued Expense?

Labiana Health's quarterly accounts payable & accrued expense increased from Dec. 2021 (€10.68 Mil) to Jun. 2022 (€15.19 Mil) but then declined from Jun. 2022 (€15.19 Mil) to Dec. 2022 (€14.41 Mil).

Labiana Health's annual accounts payable & accrued expense declined from Dec. 2020 (€11.36 Mil) to Dec. 2021 (€10.68 Mil) but then increased from Dec. 2021 (€10.68 Mil) to Dec. 2022 (€14.41 Mil).


Labiana Health Accounts Payable & Accrued Expense Historical Data

The historical data trend for Labiana Health's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Labiana Health Accounts Payable & Accrued Expense Chart

Labiana Health Annual Data
Trend Dec20 Dec21 Dec22
Accounts Payable & Accrued Expense
11.36 10.68 14.41

Labiana Health Semi-Annual Data
Dec20 Dec21 Jun22 Dec22
Accounts Payable & Accrued Expense 11.36 10.68 15.19 14.41

Labiana Health Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.


Labiana Health (XMAD:LAB) Business Description

Industry
Traded in Other Exchanges
N/A
Address
Avenida Europa, 34 1st D, Pozuelo de Alarcon, Madrid, ESP, 28023
Labiana Health SA is a manufacturer of pharmacological products for veterinary use. The company's activities include GMP manufacturer for EU animal and human health industries, manufacturer specialized in sterile and lyophilized dosage forms, source of development, acquisition, and licensing of molecules such as Fosfomycin Trometamol.